Clinical Trial Update: Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 study evaluating the safety and biologic activity of XOMA 052 in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• XOMA 052

Snippet

Sponsor: XOMA (US) LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED